Russell Global, Russell 3000, Russell 2000 and Russell Microcap Indexes added InVivo Therapeutics.
"The news comes less than three short months after our NASDAQ listing and I'm happy to be executing on the long-term benefits of being NASDAQ list," said CEO Mark Perrin. "We expect to see a significant increase in demand and liquidity from index funds looking to replicate the new Russell weightings, which will benefit our shareholders."
Here are five things to know:
1. Last year, the average three month average daily volume increased nearly three times when it was upgraded to NASDAQ for an OTC listed security.
2. NASDAQ includes 3,500 companies and $9.1 trillion market cap.
3. There are 90 percent of the Fortune 500 companies NASDAQ listed.
4. Being listed on the NASDAQ capital market puts the company in the better position to be included in indices that are tracked by "buy side institutions" and increase the likelihood of analyst coverage.
5. InVivo listed on NASDAQ on April 17, removing investment restrictions for large investors.